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ABSTRACT    
 
Purpose: Measures of body fat accumulation are associated with back pain, but a causal association is 
unclear.  We hypothesized that body mass index (BMI) would have causal effects on back pain and 
chronic back pain. To test the hypothesis, we conducted a two-sample Mendelian randomization (MR) 
study to assess the causal effect of BMI on the outcomes of 1) back pain and 2) chronic back pain 
(duration > 3 months).  
 
 
Methods: We identified genetic instrumental variables for BMI (n=60 variants) from a meta-analysis of 
genome-wide association studies (GWAS) conducted by the Genetic Investigation of ANthropometric 
Traits consortium in individuals of European ancestry (n=322,154). We conducted GWAS of back pain 
and chronic back pain (n=453,860) in a non-overlapping sample of individuals of European ancestry. 
We used inverse-variance weighted (IVW) meta-analysis as the primary method to estimate causal 
effects.   
 
Results: The IVW analysis showed evidence supporting a causal association of BMI on back pain, with 
a 1-standard deviation (4.65 kg/m2) increase in BMI conferring 1.15 times the odds of back pain (95% 
confidence interval [CI]: 1.06-1.25, p=0.001); effects were directionally consistent in secondary analysis 
and sensitivity analyses. The IVW analysis supported a causal association of BMI on chronic back pain 
(OR 1.20 per 1 SD deviation increase in BMI [95% CI 1.09-1.32; p=0.0002), and effects were 
directionally consistent in secondary analysis and sensitivity analyses. 
 
Conclusion: In this first MR study of BMI and back pain, we found a significant causal effect of BMI on 








Back pain is the leading cause of years lived with disability worldwide.1 Decreasing the burden of 
back-related disability on the population level might be achieved by targeting common modifiable risk 
factors for this prevalent and often debilitating symptom. However, the success of back pain prevention 
strategies based on risk factor modification depend entirely on whether or not the targeted risk factors 
of interest are truly causes of back pain.2 
 
Many health conditions are found more commonly in those with back pain than in those without, yet 
few of these factors have strong evidence for causal relations with back pain. Even when a risk factor 
temporally precedes and predicts an outcome, the question remains of whether the risk factor is simply 
a surrogate for another condition that is the true underlying cause. The moderate heritability of back 
pain (40%)3,4 is a reminder that shared genetic effects acting both upon back pain and putative back 
pain risk factors (pleiotropy) are a plausible explanation for many of the associations with back pain 
seen in conventional observational studies. Consistent with this, twin studies have shown that many 
associations between back pain and putative risk factors do not persist once genetics are controlled for. 
If pleiotropy explains why a risk factor predicts future back pain, then modifying that risk factor in the 
general population will have no effect on the downstream societal burden of back pain.  
 
Overweight and obesity are defined by the World Health Organization (WHO) as “abnormal or 
excessive fat accumulation that may impair health”,5 and are commonly thought of as causes of back 
pain. Body mass index (BMI), or a person's weight in kilograms divided by the square of his/her height 
in meters (kg/m2), is the most widely used population-level measure of overweight and obesity.5  
However the association of BMI and other measures of obesity with future back pain may be largely 
explained by pleiotropy, and a causal connection has been questioned based on findings from 
longitudinal twin studies, which show no association once genetic factors have been accounted for.2,6   
 
Mendelian randomization (MR) is a method that uses specific genetic variants in order to evaluate 
whether an observed risk factor-outcome association is consistent with a causal effect.7 The method 
capitalizes on the random allocation of genetic variants during gamete formation, which results in a 
random distribution of variants in a population.8 Each genetic variant may or may not affect a risk factor 
of interest. Because these genetic variants are typically independent of potentially confounding 
environmental exposures, differences in an outcome between those with and without a variant can be 
attributed to differences in the risk factor under study.8 If a risk factor (such as BMI) causes an outcome 
(such as back pain), then a genetic variant with an effect on that risk factor is expected to influence the 
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downstream outcome to a proportional degree, provided no other pathway exists by which the variant 
influences the outcome (a phenomenon known as “horizontal pleiotropy”). In such a situation, a genetic 
variant associated with a risk factor can serve as a proxy, or an “instrumental variable”, for estimating 
the causal effects of a risk factor on an outcome, and multiple genetic variants can be used 
simultaneously as instruments to increase the statistical power for estimating causal effects.7 A two-
sample MR study uses summary statistics from different non-overlapping genome-wide association 
study (GWAS) samples for the estimation of causal effects.  
  
We conducted a two-sample MR to assess the causal association of BMI on the outcomes of 1) 
back pain, and 2) chronic back pain (duration > 3 months). We hypothesized that BMI would have 




This study used both individual-level and publicly available summary-level GWAS data. Research 
ethics approvals included the UK Biobank Research Ethics Committee (#11/NW/0382) and the VA 
Puget Sound Health Care System (RDIS 0010, MIRB 00903). 
 
Data Sources and Instrument Selection 
Body Mass Index 
We selected BMI as the exposure of interest, rather than obesity or overweight categories, because 
body fat accumulation reflects a continuum that may not be fully captured by the thresholds used for 
epidemiologic purposes, and BMI is the most commonly used measure of body fat accumulation in 
population studies.5 We identified genetic instruments for BMI from a meta-analysis of GWAS of BMI 
conducted by the Genetic Investigation of ANthropometric Traits (GIANT) consortium in individuals of 
European ancestry (n=322,154).9 This GWAS examined the phenotype of BMI as determined from 
measured or self-reported weight and height, and identified 77 genetic variants, or single-nucleotide 
polymorphisms (SNPs), with an additive SNP-based heritability of 2.7%. In this GWAS, a 1-standard 
deviation change in BMI equaled 4.65 kg/m2.10 Since a SNP with a p-value exceeding genome-wide 
significance corresponds to an F statistic > 30,11 each SNP instrument had substantial strength. We  
extracted summary statistics from 
http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files. We 
excluded SNPs not present in 1000 Genomes phase 3 version 5 reference data. SNPs were clumped 
and pruned for independence in PLINK v1.9 by retaining only 1 SNP within a 10000kb window among 
SNPs correlated at r2>0.001. Last, we excluded SNPs with minor allele frequencies (MAF) < 0.05 and 
SNPs with effect vs. other allele mismatches for BMI and outcome.  
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Back Pain and Chronic Back Pain Outcomes 
 We conducted GWAS of back pain and chronic back pain (n=453,860) in a non-overlapping 
sample of individuals of European ancestry using imputed genotypes from the UK biobank (version 3) 
in PLINK v2.0. We used logistic regression to evaluate additive genetic effects of the SNPs on each 
back pain outcome as a binary trait adjusting for age, sex, genotyping array, and 10 genetic principal 
components, using filters and exclusions as described previously.12 Participants were asked the 
question “In the last month have you experienced any of the following that interfered with your usual 
activities?”. Back pain cases (n= 120,842) were defined as those who reported back pain, and controls 
(n= 333,018) as those who did not report back pain; those who declined to answer the question or 
reported pain all over their body were excluded from the analysis. A subsequent question asked “Have 
you had back pain for more than 3 months?”. Chronic back pain cases (n= 78,935) were defined as 
those who reported having had back pain for more than 3 months, and controls (n= 360,896) as those 
who reported having no back pain or denied having had back pain for more 3 months. GWAS results 
were processed using the MR-Base R package and harmonized with the set of SNP instruments; those 




To estimate the causal effect of BMI on each outcome (back pain or chronic back pain), we 
examined the association of each genetic instrument (SNP) with each exposure, and the association of 
each SNP with each outcome.  We then combined these estimates using inverse-variance weighted 
(IVW) meta-analysis.13 The IVW estimate was the primary MR effect estimate, reported as odds ratios 
(ORs) and 95% confidence intervals (95% CIs), with a p-value threshold of 0.05. Because IVW 
estimates may be biased in the presence of horizontal pleiotropy (a key MR assumption), we also 
estimated causal effects using two other methods which are robust to horizontal pleiotropy: the 
weighted median estimator and MR Egger regression methods.14-16 Both these methods are statistically 
inefficient compared to the IVW method, but MR Egger particularly so.14,15 Heterogeneity of MR 
estimates may indicate problems affecting the analyses, such as horizontal pleiotropy, or factors 
unrelated to pleiotropy, 14 and may be more likely when the outcome is binary.14,17 We examined 
heterogeneity of causal estimates using the Cochran’s Q test, the MR-Egger intercept test for 
directional horizontal pleiotropy, forest plots, funnel plots and leave-1-SNP-out analyses.   
We also examined associations between the genetic instruments and covariates relevant to back 
pain, using large publicly available GWAS (sample sizes between n=110,452 and n=766,345; 
Electronic Supplementary Content, Table S1). Covariates were grouped into two categories 
corresponding to distinct purposes. The first category included 5 covariates representing likely 
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consequences of obesity (systolic blood pressure, low-density lipoprotein cholesterol, high-density 
lipoprotein (HDL) cholesterol, type 2 diabetes, and physical activity), or causes of obesity (physical 
activity). For this category, we expected associations with the genetic instruments due to mediation (or 
“vertical pleiotropy”), which does not violate MR assumptions. The second category included 8 
covariates representing potential confounders of the BMI-back pain relationship (education, major 
depressive disorder, alcohol consumption, employment, subjective well-being, depressive symptoms, 
sleep duration, and smoking). For this category, instrument-covariate associations may reflect 
horizontal pleiotropy. A Bonferroni-corrected threshold of p <6.4 x 10-5 (0.05/60 SNP instruments x 13 
covariates) was applied. Although the practice of pruning potentially pleiotropic variants is controversial 
due to the potential for imparting bias rather than removing it,7 we conducted a sensitivity analysis 
excluding SNP instruments associated potential confounders, and also excluding SNPs identified as 
outliers by the MR-PRESSO (Pleiotropy Residual Sum and Outlier) residual sum and outlier test.18 
Statistical precision in the sensitivity analyses was expected to be decreased compared to the primary 
analysis, due to using fewer genetic instruments. 
 
 RESULTS  
 Of 77 SNPs, 60 met inclusion criteria and were used as genetic instrumental variables.  The IVW 
analysis results supported a causal association of BMI on back pain, with a 1-SD unit (4.65 kg/m2) 
increase in BMI conferring 1.15 times the odds of back pain (95% CI 1.06-1.25, p=0.001); effects were 
directionally consistent with the weighted median and MR Egger methods, though not statistically 
significant (Table 1). The Cochran’s Q test indicated heterogeneity of causal estimates (p<0.0001), as 
did forest and funnel plots, but other assessments did not indicate heterogeneity (Electronic 
supplementary material, Table S2, Figures S1-S3). Examination of instrument-covariate associations 
revealed 16 SNPs significantly associated with covariates and expected to lie along the causal pathway 
connecting obesity and back pain, with most associations seen for systolic blood pressure (9 SNPs) 
and HDL cholesterol (5 SNPs) (Electronic supplementary material, Table S1). Significant associations 
were also found for 16 SNPs thought to be potential confounders, with the most associations seen for 
educational attainment (10 SNPs) and alcohol intake (8 SNPs). In sensitivity analyses excluding the 16 
SNP instruments that were potential confounders and 7 significant outliers identified by MR-PRESSO 
(leaving 37 instruments), there was no indication of heterogeneity (Electronic supplementary material, 
Table S1, Figures S4-S6). Sensitivity analyses showed similar direction and magnitude effects as the 
main analyses (Table 1). 
 
The IVW analysis also supported a causal association of BMI on chronic back pain (OR 1.20 per 1 
SD deviation increase in BMI [95% 1.09-1.32; p=0.0002) and effects with other methods were 
directionally consistent (Table 1). The Cochran’s Q test indicated heterogeneity (p<0.0001), as did 
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forest and funnel plots (Electronic supplementary material, Table S2, Figures S7-S9). In sensitivity 
analyses excluding the 16 SNP instruments that were potential confounders and 6 significant outliers 
identified by MR-PRESSO (Electronic supplementary material, Figures S10-S12), the direction and 
magnitude of effects were generally similar to the main analyses (Table 1). 
DISCUSSION 
Measures of obesity are often considered risk factors for the development of back pain, yet it has 
been unclear whether a higher BMI actually causes back pain. The current study used MR to address 
this uncertainty. We found evidence supporting causal associations of BMI on back pain (OR=1.15 per 
SD of BMI) and chronic back pain (OR=1.20 per SD of BMI).   
 
A recent meta-analysis of cohort studies by Zhang et. al compared the incidence of back pain in 
those with WHO-defined overweight (BMI 25.0-29.9) vs. normal weight (BMI 18.5-24.9), in which 
between-category BMI differences would be expected to average between 5 and 6 kg/m2.19  Zhang et. 
al. estimated an OR of 1.15 (95% CI 1.08–1.21) of incident back pain for overweight vs. normal weight 
individuals,19 a magnitude of effect that is closely comparable with the current study’s MR estimate of 
BMI on back pain (OR=1.15 per 4.65 kg/m2 of BMI). This similarity between observational and MR 
estimates indicates that the association between BMI and back pain from conventional observational 
studies is likely not explained by shared genetic factors predisposing to both conditions. This inference 
contrasts with findings from longitudinal twin studies in which associations between BMI and future 
back pain become non-significant once accounting for genetic factors.20,21 However, the different 
conclusions reached are well-explained by the small numbers of monozygotic twins informing the co-
twin control estimates (between 60 and 156 participants),20,21 and the current analysis of data from 
776,014 participants had substantially greater power to detect an effect of BMI.  
 
Randomized trials of intensive weight loss interventions in knee osteoarthritis (OA) have significant 
yet modest effect sizes on pain (Cohen’s d = 0.33) and disability (Cohen’s d = 0.42).22 Our MR estimate 
of BMI on back pain (OR =1.15) is considerably smaller than that from a recent MR study examining 
the causal associations of BMI on knee OA23 (OR 1.76 [95% 1.56-1.99]; p=1.5 x 10-31), which used the 
same exposure and outcome datasets as the current study. This is perhaps unsurprising given the 
heterogeneity of conditions which underlie the symptom of back pain, in contrast to the more specific 
phenotype of knee OA. However, it suggests that treatments based on intensive BMI reduction alone 
may have quite small effects on limiting back pain and disability in large groups of people. Multifaceted 
lifestyle interventions addressing several modifiable risk factors simultaneously, including BMI, may 
have greater potential for achieving larger effects on back pain. A trial of one such lifestyle intervention 
is currently underway.24 Given that our MR estimates pertain to risk conferred by lifelong differences in 
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BMI, it is also possible that protective effects stemming from interventions to  reduce BMI (or maintain 
low BMI) may require such interventions to take place in childhood or adolescence, and might not yield 
results if applied to older adults.   
 
   To our knowledge, this is the first MR study of the effects of BMI on back pain. The validity of 
conclusions drawn from MR depend on several assumptions, of which the absence of meaningful 
horizontal pleiotropy is central. Our analyses of SNP instrument-covariate associations indicated 
possible pathways reflecting horizontal pleiotropy. Nevertheless, methods robust to horizontal 
pleiotropy (weighted median and MR Egger) yielded results that were directionally consistent with IVW 
analyses and of generally comparable magnitude. In addition, sensitivity analyses excluding 
instruments associated with potential confounders yielded results that comparable to the main 
analyses, albeit with reduced statistical power due to fewer SNP instruments.  A possible limitation of 
our study was that the back pain questions used did not allow specification of the precise location 
where back pain was occurring (e.g. low back vs. midback). Given the high agreement between general 
back pain and low back pain questions,3 and since midback pain without concurrent low back pain is 
less common,25 we expect that our findings regarding causal effects of BMI pertain also to low back 
pain. Future MR studies should examine low back pain specifically, as well as lumbar spine 
endophenotypes such as lumbar disc herniation.  
 
CONCLUSIONS 
In summary, we conducted the first MR study of the effects of obesity on back pain. Our findings 
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